Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm
- PMID: 32505909
- PMCID: PMC7261102
- DOI: 10.1016/j.mehy.2020.109897
Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
On the Alert for Cytokine Storm: Immunopathology in COVID-19.Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. doi: 10.1002/art.41285. Epub 2020 May 10. Arthritis Rheumatol. 2020. PMID: 32293098 Free PMC article.
-
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.Eur Respir J. 2020 Oct 1;56(4):2003006. doi: 10.1183/13993003.03006-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32883678 Free PMC article.
-
COVID-19: Some clinical questions after the first 4 months.Eur J Clin Invest. 2020 Jul;50(7):e13326. doi: 10.1111/eci.13326. Epub 2020 Jul 5. Eur J Clin Invest. 2020. PMID: 32562550 Free PMC article. No abstract available.
-
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.Int Immunopharmacol. 2020 Sep;86:106749. doi: 10.1016/j.intimp.2020.106749. Epub 2020 Jul 1. Int Immunopharmacol. 2020. PMID: 32645632 Free PMC article. Review.
-
The COVID-19 Cytokine Storm; What We Know So Far.Front Immunol. 2020 Jun 16;11:1446. doi: 10.3389/fimmu.2020.01446. eCollection 2020. Front Immunol. 2020. PMID: 32612617 Free PMC article. Review.
Cited by
-
COVID-19: Gastrointestinal manifestations, liver injury and recommendations.World J Clin Cases. 2022 Feb 6;10(4):1140-1163. doi: 10.12998/wjcc.v10.i4.1140. World J Clin Cases. 2022. PMID: 35211548 Free PMC article. Review.
-
Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19.World J Gastroenterol. 2021 Dec 28;27(48):8370-8373. doi: 10.3748/wjg.v27.i48.8370. World J Gastroenterol. 2021. PMID: 35068875 Free PMC article.
-
Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity.Microorganisms. 2023 Feb 10;11(2):452. doi: 10.3390/microorganisms11020452. Microorganisms. 2023. PMID: 36838417 Free PMC article. Review.
-
Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis.Int J Mol Sci. 2021 Jan 30;22(3):1397. doi: 10.3390/ijms22031397. Int J Mol Sci. 2021. PMID: 33573273 Free PMC article. Review.
-
Liver injury in the era of COVID-19.World J Gastroenterol. 2021 Feb 7;27(5):377-390. doi: 10.3748/wjg.v27.i5.377. World J Gastroenterol. 2021. PMID: 33584070 Free PMC article. Review.
References
-
- Kim Y.J., Jeong S.H., Kim E., Kim E.J., Cho J.H. Ursodeoxycholic acid suppresses epithelial-mesenchymal transition and cancer stem cell formation by reducing the levels of peroxiredoxin II and reactive oxygen species in pancreatic cancer cells. Oncol Rep. 2017;38(6):3632–3638. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources